Mark Andrew Wilson, Chief Legal Officer at NEKTAR THERAPEUTICS (NKTR), sold 11,040 shares at $1.01 ($11K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Seasonal sale ($11k) by Chief Legal Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |
| NKTR | SELL | 2024-11-20 | $6K | — | Filing → |